CS154295B2 - - Google Patents

Info

Publication number
CS154295B2
CS154295B2 CS155770A CS155770A CS154295B2 CS 154295 B2 CS154295 B2 CS 154295B2 CS 155770 A CS155770 A CS 155770A CS 155770 A CS155770 A CS 155770A CS 154295 B2 CS154295 B2 CS 154295B2
Authority
CS
Czechoslovakia
Application number
CS155770A
Other languages
Czech (cs)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CS154295B2 publication Critical patent/CS154295B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
    • C07D223/28—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a single bond between positions 10 and 11

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
CS155770A 1969-03-31 1970-03-09 CS154295B2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH484469A CH505101A (de) 1969-03-31 1969-03-31 Verfahren zur Herstellung von neuen Azepinderivaten

Publications (1)

Publication Number Publication Date
CS154295B2 true CS154295B2 (fr) 1974-03-29

Family

ID=4283538

Family Applications (1)

Application Number Title Priority Date Filing Date
CS155770A CS154295B2 (fr) 1969-03-31 1970-03-09

Country Status (20)

Country Link
AT (1) AT294106B (fr)
BE (1) BE747086A (fr)
BG (1) BG17600A3 (fr)
BR (1) BR7017333D0 (fr)
CA (1) CA920587A (fr)
CH (1) CH505101A (fr)
CS (1) CS154295B2 (fr)
DE (1) DE2011045C3 (fr)
DK (1) DK133898B (fr)
ES (1) ES377280A1 (fr)
FI (1) FI50524C (fr)
FR (1) FR2035999B1 (fr)
GB (1) GB1310120A (fr)
IE (1) IE34050B1 (fr)
IL (1) IL34027A (fr)
NL (1) NL159972C (fr)
NO (1) NO131546C (fr)
PL (1) PL80544B1 (fr)
SE (1) SE354069B (fr)
YU (1) YU33863B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE789320A (fr) * 1971-09-30 1973-03-27 Takeda Chemical Industries Ltd Derives de dibenzoxirenazepine
EP0108715A1 (fr) * 1982-10-15 1984-05-16 Ciba-Geigy Ag Dibenzazépinecarboxamides
PT101732B (pt) * 1995-06-30 1997-12-31 Portela & Ca Sa Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso
US20020022056A1 (en) 1997-02-14 2002-02-21 Burkhard Schlutermann Oxacarbazepine film-coated tablets
AT408224B (de) * 1999-03-15 2001-09-25 Dsm Fine Chem Austria Gmbh Verfahren zur herstellung von oxcarbazepin
HUP0402381A3 (en) 2001-11-12 2008-01-28 Novartis Ag Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain
GB0303615D0 (en) * 2003-02-17 2003-03-19 Novartis Ag Use of organic compounds
ITMI20042230A1 (it) * 2004-11-19 2005-02-19 Farchemia Srl Procedimento per la preparazione della 10,11-diidro-10 idrossi-5h-dibenz-b,f-azepin-5carbossiammide
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies

Also Published As

Publication number Publication date
NO131546C (fr) 1975-06-25
BR7017333D0 (pt) 1973-05-31
SE354069B (fr) 1973-02-26
NL7003026A (fr) 1970-10-02
FR2035999B1 (fr) 1973-04-06
BE747086A (fr) 1970-09-09
IL34027A (en) 1972-12-29
PL80544B1 (fr) 1975-08-30
IE34050B1 (en) 1975-01-22
DE2011045B2 (de) 1978-10-05
NL159972C (nl) 1979-09-17
FI50524C (fi) 1976-04-12
DK133898C (fr) 1977-03-07
YU33863B (en) 1978-06-30
IE34050L (en) 1970-09-30
CH505101A (de) 1971-03-31
DE2011045C3 (de) 1979-05-31
NO131546B (fr) 1975-03-10
FI50524B (fr) 1975-12-31
DE2011045A1 (de) 1970-10-08
GB1310120A (en) 1973-03-14
ES377280A1 (es) 1972-06-16
YU53770A (en) 1977-12-31
IL34027A0 (en) 1970-05-21
CA920587A (en) 1973-02-06
AT294106B (de) 1971-11-10
BG17600A3 (fr) 1973-11-10
DK133898B (da) 1976-08-09
FR2035999A1 (fr) 1970-12-24

Similar Documents

Publication Publication Date Title
CS154294B2 (fr)
AU2270770A (fr)
AU429630B2 (fr)
FR2035999B1 (fr)
AU2355770A (fr)
AU427401B2 (fr)
AU428131B2 (fr)
AU417208B2 (fr)
AT308690B (fr)
AU428074B2 (fr)
AU428129B2 (fr)
AU438128B2 (fr)
AU425297B2 (fr)
AU410358B2 (fr)
AU414607B2 (fr)
AU4923469A (fr)
AR203167Q (fr)
CS149287B1 (fr)
CS149917B2 (fr)
AU1036070A (fr)
CH571487A5 (fr)
CH559752A5 (fr)
NL7008904A (fr)
AU4815038A (fr)
AU436893A (fr)